Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

NCT06290856 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06290856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06290856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
Lead sponsor
Oslo University Hospital
Phase
Observational
Overall status
Terminated
Start date
January 15, 2024
Completion date
July 15, 2024
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, metastatic colorectal cancer, pancreas adenocarcinoma